Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients

Clinical trial NCT03184467 · COMPLETED

Trial details

NCT number: NCT03184467
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2017-09-05
Primary completion: 2019-09-05
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.